JERUSALEM, Israel, Dec. 06, 2017 -- IDenta Corp. (OTC Pink: IDTA), a worldwide leader in the development of field drug and explosive detection kits and unique forensic products, had a very successful week at the Milipol exhibition in November, in Paris. The IDenta pavilion had hundreds of visitors from dozens of countries, wanting to learn about the company and its unique products. The company displayed a variety of drug and explosive detection kits. In addition, a new generation of innovative detection products was also unveiled. These products are for use in the field for forensic and crime scene analysis. They far exceed, in quality and ease of use, anything else that is currently on the market. IDenta and its products were covered by local TV channels along with extensive coverage of the exhibition itself. The films will soon be broadcast in wide circulation.
Amichai Glattstein, COO of IDenta: “The Milipol exhibition is a major annual event in the security world. It takes place once every two years in Paris with thousands of participants from all over the world. This is the third time IDenta has exhibited in this important exhibition. We are excited about the hundreds of visitors who expressed serious interest in our products and our innovations in the security and forensic market. We anticipate significantly increased sales, penetrating new worldwide markets in 2018, based on the contacts made at this year’s Milipol Exhibition.”
About IDenta Corp.
Since 2002, IDenta Corporation and its subsidiary IDenta Ltd has been recognized as a worldwide leader in the development of proprietary on-site Drug, Drug Precursor and Explosive detection kits. IDenta develops, manufactures and distributes revolutionary products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.
Safe Harbor Statement
Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
Company Contact Information: Amichai Glattstein, COO Tel: +972-2-5872220 E: [email protected]


Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Washington Post Publisher Will Lewis Steps Down After Layoffs
Instagram Outage Disrupts Thousands of U.S. Users
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 



